StockMarketWire.com - Verona Pharma - the drug development company focused on first-in-class medicines to treat respiratory diseases - expects to announce its preliminary results for the year ended 31 December on 3 June.


At 2:57pm: [LON:VRP] Verona Pharma PLC share price was 0p at 3.45p



Story provided by StockMarketWire.com